BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21418542)

  • 1. Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution.
    Cooper PC; Siddiq S; Morse C; Nightingale J; Mumford AD
    Int J Lab Hematol; 2011 Oct; 33(5):451-6. PubMed ID: 21418542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.
    Tjeldhorn L; Sandset PM; Haugbro K; Skretting G
    Thromb Res; 2010 Mar; 125(3):230-4. PubMed ID: 19535131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide)).
    Simioni P; Kalafatis M; Tormene D; Luni S; Zerbinati P; Barzon L; Palù G; Girolami A
    Thromb Haemost; 2001 Oct; 86(4):1017-22. PubMed ID: 11686318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter comparison of five functional and two immunological assays for protein C.
    Mannucci PM; Boyer C; Tripodi A; Viganò-D'Angelo S; Wolf M; Valsecchi C; D'Angelo A; Meyer D; Larrieu MJ
    Thromb Haemost; 1987 Feb; 57(1):44-8. PubMed ID: 3590079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays.
    Ding Q; Yang L; Dinarvand P; Wang X; Rezaie AR
    Blood; 2015 Apr; 125(15):2428-34. PubMed ID: 25651845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotypic and genetic assessment of protein C deficiency.
    Cooper PC; Hill M; Maclean RM
    Int J Lab Hematol; 2012 Aug; 34(4):336-46. PubMed ID: 22321166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical activity and gene analysis of inherited protein C and antithrombin deficiency in two Chinese pedigrees.
    Zhou RF; Fu QH; Wang WB; Xie S; Hu YQ; Wang XF; Wang ZY; Wang HL
    Chin Med J (Engl); 2004 Jun; 117(6):813-7. PubMed ID: 15198878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
    Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
    Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A sporadic case of protein C deficiency].
    Ishimaru F; Hayashi H; Ueki K; Fujita T; Tsurumi N; Tsuda T; Kimura I
    Rinsho Ketsueki; 1990 Nov; 31(11):1856-61. PubMed ID: 2287072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro CR global: an effective screening test for thrombophilia.
    Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
    Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification.
    Marlar RA; Adcock DM; Madden RM
    Thromb Haemost; 1990 Jun; 63(3):375-9. PubMed ID: 2402741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
    D'Angelo SV; Gilardoni F; D'Angelo A
    Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory tests for protein C deficiency.
    Khor B; Van Cott EM
    Am J Hematol; 2010 Jun; 85(6):440-2. PubMed ID: 20309856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
    Geng JP; Cheng CH; Castellino FJ
    Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.